These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 3121562)
21. Synergistic cytotoxicity of recombinant human TNF and various anti-cancer drugs. Watanabe N; Niitsu Y; Yamauchi N; Ohtsuka Y; Sone H; Neda H; Maeda M; Urushizaki I Immunopharmacol Immunotoxicol; 1988; 10(1):117-27. PubMed ID: 2452179 [TBL] [Abstract][Full Text] [Related]
22. Antitumor activity of TNF-alpha, IL-1, and IFN-gamma against three human osteosarcoma cell lines. Jia SF; Kleinerman ES Lymphokine Cytokine Res; 1991 Aug; 10(4):281-4. PubMed ID: 1932372 [TBL] [Abstract][Full Text] [Related]
23. Synergistic enhancement of the antitumor activity of recombinant human TNF-alpha by recombinant human IFN-gamma. Taguchi T; Abe S; Nakano K; Matsui Y; Sohmura Y Cancer Detect Prev; 1988; 12(1-6):105-14. PubMed ID: 3141050 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic potential of natural human tumor necrosis factor-alpha in combination with natural human interferon-alpha or -gamma on human cancer cells. Shiiki S; Fuchimoto S; Orita K Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):345-51. PubMed ID: 3141998 [TBL] [Abstract][Full Text] [Related]
25. In-vitro anti-proliferative effects of some anti-tumour drugs on feline mammary tumour cell lines. Muleya JS; Nakaichi M; Taura Y; Yamaguchi R; Nakama S Res Vet Sci; 1999 Jun; 66(3):169-74. PubMed ID: 10333454 [TBL] [Abstract][Full Text] [Related]
26. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells. Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391 [TBL] [Abstract][Full Text] [Related]
27. The combination of gamma-interferon and tumor necrosis factor causes a rapid and extensive differentiation of human neuroblastoma cells. Ponzoni M; Casalaro A; Lanciotti M; Montaldo PG; Cornaglia-Ferraris P Cancer Res; 1992 Feb; 52(4):931-9. PubMed ID: 1371090 [TBL] [Abstract][Full Text] [Related]
28. Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of a human salivary gland cell line. Wu AJ; Kurrasch RH; Katz J; Fox PC; Baum BJ; Atkinson JC J Cell Physiol; 1994 Nov; 161(2):217-26. PubMed ID: 7962105 [TBL] [Abstract][Full Text] [Related]
29. Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis. Schiller JH; Groveman DS; Schmid SM; Willson JK; Cummings KB; Borden EC Cancer Res; 1986 Feb; 46(2):483-8. PubMed ID: 2416427 [TBL] [Abstract][Full Text] [Related]
30. Synergistic cytotoxic effects of tumor necrosis factor, interferon-gamma and tamoxifen on breast cancer cell lines. Matsuo S; Takano S; Yamashita J; Ogawa M Anticancer Res; 1992; 12(5):1575-9. PubMed ID: 1444224 [TBL] [Abstract][Full Text] [Related]
31. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors. Kost ER; Mutch DG; Herzog TJ Gynecol Oncol; 1999 Mar; 72(3):392-401. PubMed ID: 10053112 [TBL] [Abstract][Full Text] [Related]
32. Synergistic antitumor effects of natural human tumor necrosis factor-alpha and natural human interferon-alpha or -gamma on human cancer cell lines. Shiiki S; Fuchimoto S; Orita K Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):87-97. PubMed ID: 2501839 [TBL] [Abstract][Full Text] [Related]
33. Synergistic induction of polypeptides by tumor necrosis factor and interferon-gamma in cells sensitive or resistant to tumor necrosis factor: assessment by computer based analysis of two-dimensional gels using the PDQUEST system. Beresini MH; Sugarman BJ; Shepard HM; Epstein LB Electrophoresis; 1990 Mar; 11(3):232-41. PubMed ID: 2111772 [TBL] [Abstract][Full Text] [Related]
34. Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons. Vita JR; Edwalds GM; Gorey T; Housepian EM; Fetell MR; Guarini L; Langer JA; Fisher PB Anticancer Res; 1988; 8(3):297-302. PubMed ID: 2839097 [TBL] [Abstract][Full Text] [Related]
35. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. Selleri C; Sato T; Anderson S; Young NS; Maciejewski JP J Cell Physiol; 1995 Dec; 165(3):538-46. PubMed ID: 7593233 [TBL] [Abstract][Full Text] [Related]
36. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Morimoto H; Yonehara S; Bonavida B Cancer Res; 1993 Jun; 53(11):2591-6. PubMed ID: 7684321 [TBL] [Abstract][Full Text] [Related]
37. Combined effect of 5-fluorouracil and recombinant tumor necrosis factor against human gastric carcinoma cell lines. Li Y; Ito S; Cheng W; Ishii Y Anticancer Res; 1996; 16(4A):1771-4. PubMed ID: 8712699 [TBL] [Abstract][Full Text] [Related]
38. Studies on the natural killer cell activity of human nonadherent mononuclear cells (nMNC) with tumor necrosis factor, interleukin-1, interferon-gamma and cisplatin. Pai K; Sodhi A Neoplasma; 1992; 39(6):363-7. PubMed ID: 1491726 [TBL] [Abstract][Full Text] [Related]
39. Apoptosis of cultured mouse luteal cells induced by tumor necrosis factor-alpha and interferon-gamma. Jo T; Tomiyama T; Ohashi K; Saji F; Tanizawa O; Ozaki M; Yamamoto R; Yamamoto T; Nishizawa Y; Terada N Anat Rec; 1995 Jan; 241(1):70-6. PubMed ID: 7879925 [TBL] [Abstract][Full Text] [Related]
40. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines. Morikage T; Ohmori T; Nishio K; Fujiwara Y; Takeda Y; Saijo N Cancer Res; 1993 Jul; 53(14):3302-7. PubMed ID: 8391922 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]